---
title: "BSX.US (BSX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BSX.US/news.md"
symbol: "BSX.US"
name: "BSX.US"
parent: "https://longbridge.com/en/quote/BSX.US.md"
datetime: "2026-05-20T07:41:56.791Z"
locales:
  - [en](https://longbridge.com/en/quote/BSX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BSX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BSX.US/news.md)
---

# BSX.US (BSX.US) — Related News

### [Sector Update: Healthcare Stocks Rise Tuesday Afternoon](https://longbridge.com/en/news/286953270.md)
*2026-05-19T18:02:00.000Z*
> Healthcare stocks rose on Tuesday, with the NYSE Healthcare Index up 1.1% and the State Street Healthcare Select Sector 

### [Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results](https://longbridge.com/en/news/286942821.md)
*2026-05-19T16:01:31.000Z*
> Boston Scientific announced positive results from the FRACTURE trial for its SEISMIQ 4CE coronary IVL catheter, achievin

### [FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints | BSX Stock News](https://longbridge.com/en/news/286895834.md)
*2026-05-19T02:35:36.000Z*
> FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safet

### [Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years](https://longbridge.com/en/news/286831761.md)
*2026-05-18T23:00:38.000Z*
> Boston Scientific (NYSE:BSX) has delivered an average annual return of 15.23% over the past 15 years, outperforming the 

### [Boston Scientific Corporation Stock 12‑Month Price Target Cut to $83.7, Implies 59% Upside](https://longbridge.com/en/news/286824907.md)
*2026-05-18T22:20:08.000Z*
> Boston Scientific Corporation's average stock price target has been reduced from $85.03 to $83.8, suggesting a potential

### [3 Best Stocks to Buy This Week, According to Analysts – May 18-May 22](https://longbridge.com/en/news/286816644.md)
*2026-05-18T20:12:08.000Z*
> Analysts recommend three stocks for this week: Zeta Global (ZETA), Boston Scientific (BSX), and Summit Therapeutics (SMM

### [Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal](https://longbridge.com/en/news/286808399.md)
*2026-05-18T18:40:00.000Z*
> Boston Scientific Corporation (BSX) has invested $1.5 billion in MiRus, acquiring a 34% equity stake and an option to bu